How do consumer insights fuel our innovation?

From bench to bedside: lessons in converting science into impact

How a chance encounter led to a world-first toothpaste

Did you know that NovaMin, one of the key technologies in our toothpaste, is actually a bioactive glass most commonly used to repair bones?

TB: uniting scientists to tackle one of the world’s biggest killers

Tuberculosis – better known as TB – is one of the top ten causes of deaths worldwide. But for the first time in almost 100 years, we have taken a major step towards finding a potential new vaccine against the disease.

Inside the Open Lab

How does the Tres Cantos Open Lab offer top international scientists and academics the opportunity to pursue their own projects as part of an integrated team?

Vaccines of tomorrow

Join our leading scientists as they go behind the science of vaccine technology.

You, me and 23andMe: discovering new medicines through genetics

Overcoming obstacles to end malaria

The little pill that could: one medicine taking on two neglected diseases

This pill is part of the fight against not one – but two – neglected tropical diseases(NTDs) that burden some of the very poorest communities.

Severe asthma: when nature’s natural defences work against us

Around 36 million people around the world are living with severe asthma. But, hope could be on the horizon thanks to a better understanding of how certain blood cells malfunction.

Complete the cycle – how we’re recycling inhalers

When we analysed our carbon footprint in 2010, two things became clear: we needed to take action to reduce it.

Fighting malaria in the lab and on the ground

Despite progress to fight malaria, millions of people continue to suffer every year. We’re helping by researching medicines and vaccines, supporting community prevention and health worker training and strengthening access to medicines.

How do consumer insights fuel our innovation?

How genomics is driving a new era of drug discovery

How are we redefining research in HIV?

Shari Gordon works in the HIV Cure Center in North Carolina, a public-private company with one goal: discovering a cure for HIV/AIDS.

Following the journey of a respiratory medicine

Elaine Jones explains how her passion for helping respiratory patients live every breath motivates her in developing new medicines.

Lupus: the search for a cure continues

Doctors and their patients face an ongoing battle to manage this chronic and sometimes debilitating and life-threatening condition. See how we’re trying to help.

COPD for John just means doing everything at a slower pace

Meet John - at 80 years old, he refuses to let COPD get in the way of living the life he wants to.

Making the Ellipta® inhaler a reality

Overcoming the challenges of COPD to fulfil a lifelong dream

Making sense of what consumers want

As a Principal Sensory Scientist in our Consumer Sensory Lab, Hyung describes how we develop products that spark the sensory reaction consumers want.

The science of shopping

Every day millions of consumers use our products. Different countries have different needs and consumers’ shopping habits vary hugely.

Breaking through the pain barrier: our latest research

From a passing headache to chronic back pain, we are working hard to better understand why we experience pain and develop more effective pain relief treatments.

I control my asthma, it doesn’t control me

Jamie from our Montrose site tells how he managed his asthma to conquer Mount Kenya

Thank you for calling GSK. Meet Paul, the voice at the end of the line.

You'll outgrow some childhood habits, but vaccination is for life

How curious minds saved a medicine from being left in the lab

See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine.

Does lupus really know no boundaries?

There are no boundaries when it comes to the impact of lupus; it can affect any part of the body in any way at any time, often with unpredictable and life-changing results.

From TV to tackling lupus: why Alex moved from media to medicine

Alex Liakos on becoming a lupus medic, and listening to the patient

Giving a bit back – Christine’s experience of clinical research

For Christine even gentle exercise like jogging and walking her dogs around the park were a struggle. She just could not breathe properly.

Healthcare in your pocket

The race against malaria: handing the baton to the next generation

Win for Meningitis – harnessing the power of inspirational images to create a win for disease prevention

Through our Win for Meningitis campaign, we’re helping to raise awareness of this damaging disease.

Setting the record straight: Why we publish data both positive and negative

Sharing our trial results, regardless of whether they reflect positively or negatively on our medicines is the right thing to do.

Making the switch: how we’re improving access to proven medicines

Switching a medicine from prescription to over-the-counter places the power of managing everyday health conditions with the patient.

Supporting community health across the UK

Our GSK IMPACT Awards have been rewarding community health and wellbeing charities for the past 20 years.

30 years and counting: the fight against HIV

HIV research focus on finding a cure

What are Bioelectronics

We’re all familiar with the life-saving impact of pacemakers and defibrillators on the heart.

Live every breath

GSK have been innovating to fight respiratory disease for over 45 years.

Vaccines: the most successful health intervention… ever

Vaccines for preventable diseases

Joining forces to fight malaria

We’ve been fighting against malaria for the past 100 years and now we’ve joined forces with Comic Relief.

STEM inspiring real world scientists

The digitalisation lab: bringing the digital age to manufacturing

From academia to the pharmaceutical industry – one year on

Professor Ronald Dahl recently joined GSK as a Global Medical Expert in the GSK Global Respiratory Franchise.

COPD: Our relentless pursuit for better breathing

Every person with COPD is different, with different needs, different challenges and different goals. See how we're innovating to determine the right treatment for the right patient.

Taking action to stop pneumonia

Pneumonia is a preventable and treatable disease.

Getting on target in autoimmune diseases

Our immune system is a complex network of cells in our bodies that work together to protect us from harmful germs.But what happens when these cells malfunction?

How smart is your inhaler?

Maternal immunisation: Helping protect mums and babies

Can social media help us hear patients?

Understanding the benefits and risks of medicine from a patient’s point of view is important to the evaluation of our medicines.

Tackling tomorrow’s health challenges today

Our Chief Scientist, Rino Rappuoli, explains how science is helping create the vaccines of tomorrow

Don’t forget the pharmacists

Dr. Sharmila Ramachandran and Dr. Aruni Mulgirigama talk about the essential role of pharmacists in asthma care

Rabies – Educate, Vaccinate, Eliminate.

28 September is World Rabies Day, when organisations across the globe, all with the common goal of eliminating human deaths from rabies by 2030, work together to raise awareness of this ‘neglected tropical disease’ under the theme ‘Educate, Vaccinate, Eliminate’.

Partnership for Prevention

Scientists or detectives? Seeking new clues in COPD

Collaboration: unlocking a new approach to clinical trials

The Salford Lung Study is a revolutionary clinical trial carried out in everyday practice that could significantly increase our understanding of the medicines doctors prescribe.

Helping to change the world

FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.

A new response to humanitarian crises

Humanitarian crises are becoming more frequent, more widespread and more complex. It’s clear that a new approach is needed.

A partnership that is all about the chemistry

See how our trainer trains sub Saharan Africa scientists in analytical chemistry.

Can an iPhone transform the way we monitor and improve patient health?

The app that could save lives

Changing gears in a scientific career

GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier.

Inhaler innovation: more than a simple piece of plastic

At first glance, an inhaler may look like a simple piece of plastic. But inside, a complicated process and an internal ‘engine’ operate seamlessly...

From microscope to telescope and beyond – exploring with NASA's CASIS

What do space exploration and medical research have in common? And can they help each other?

Meet Baby Mckline: a special delivery from our Save the Children partnership

Mckline is a special little boy. Almost two years old, he lives in Kenya with his parents Catherine and Fredrick. They are already saving for his education and have ambitions for him to be an engineer one day.

Pro Mujer: supporting healthier lives in Latin America

From academia to industry: a new challenge

The design behind the device

Andy Dundon leads our R&D Device Engineering team in Ware, UK. His team focuses on ways to improve the design of our drug delivery devices

An 'everyday' world first in clinical trials

The way we design and carry out clinical trials is being turned on its head by the advent of the Salford Lung Study (SLS).

Turning the tide on antibiotic resistance

Picture a world where people routinely die from minor infections. With an alarming rise in antibiotic resistance in recent years, this almost unthinkable scenario could be a reality.

Guardian article: The 30-year quest for a malaria vaccine

Dr Joe Cohen recalls his experiences of being part of the team to develop what could be the world’s first vaccine against malaria

Clinical Trials: Q&A with Murray Stewart

Giving mothers and babies a healthier start

Safety first: Employee wellbeing rides on it

Rajendra is a medical representative in India. He commutes 30 kilometres everyday by motorcycle - and that doesn't even include the time spent on the road during the day.

Vaccine manufacture: it’s complicated

Vaccine manufacture can take anywhere between 6 and 26 months. That’s not to mention the time required to research and develop a new vaccine, which can take up to 30 years.

The power of partnerships: transforming vaccine coverage in Mozambique

More than 35,000 children in the northern Mozambique province of Nampula are now registered with the mVacciNation pilot programme that was rolled out in 2015 by GSK and Vodafone, with funding from GAVI and USAID.

The value of vaccination

According to the World Health Organization, only clean drinking water rivals vaccination in its ability to save lives.

Beyond manufacturing in Chile and Madagascar

Why I #fightmalaria: Laura's story

Playing the innovation game

Besides good timing and even better luck, it’s hard to pinpoint what it takes to be an innovator. Innovators tend to be creative, exceptionally persistent, and prepared to take calculated risks.

Living with lupus – a patient perspective

Beth, a lupus patient, provides insights into the day-to-day challenges of living with this chronic condition.

Take a deep breath – your lung microbiome will appreciate it

Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity.

Helping to further science and research – Howard’s perspective

The Salford Lung Study is a ground breaking clinical trial that explores how effective a treatment for COPD is in everyday life.

TB or not TB

Bioelectronics at SXSW 2016

Delivering support for the most vulnerable communities

Healthcare charities tackle some of society’s most difficult and often overlooked challenges.

School leading the way to inspire young scientists

Dr Louise Morris wants every student at her school to have the education and opportunity to have a career in STEM.

Harnessing the electrical language of the body to treat disease

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

Telegraph article: Science hasn't answered all the questions on HIV

Dr Kimberly Smith, vice president of medical strategy at ViiV Healthcare, shares her experiences of a career spent working to find a cure for the disease.

Igniting a revolution in scientific research and development

Guardian article: Making a change from the inside

Guardian article: A different way of doing business to support Kenyan mothers

Find out how we are helping to cut maternal and newborn mortality rates in Kenya.

See how GSK supports STEM in the real world

Explore how we invest in the scientists of the future.

Guardian article: Finding new ways to give mothers and newborns a healthier start

Scientist Lori Gavrin has first-hand experience of why we need to find new ways to help protect mothers and their newborn babies

Turning waste into a resource

We set a target to achieve ‘zero waste to landfill’ at all our sites by 2020. Already, over 60% of GSK sites and offices have achieved the target.

Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective

Comic Relief and GSK form a partnership to fight malaria

Intrapreneurship: keeping our fingers on the PULSE

We're encouraging our employees to explore new ideas beyond the remit of their role

Turbocharging the effect of vaccines

When extracted and purified, a compound from the soap bark tree can be mixed with other ingredients to create an ‘adjuvant’, turbocharging the body's immune defences.

Helping to protect yourself against flu

Influenza, commonly called ‘the flu’, is a contagious infection of the respiratory tract, which affects people of all ages.

Experimental medicine

Studies often employ state-of-the art technology to help scientists and doctors track the effect of a potential new medicine in patients’ bodies.

Outgrowing asthma

TEDMED 2015: An interview with curator, Christine McNab

STEM in the real world

At Waldegrave School for Girls in Twickenham there is a drive to enthuse pupils about the possibilities and opportunities that STEM subjects can offer.

TEDMED 2015: Art, inspired by vaccination

A blank canvas, Unformed clay. An empty petri dish.

Living every day with COPD: José’s story

Simple activities are an everyday struggle for people living with COPD. José gives his perspective on the impact that COPD has on him.

Guardian article: Why I put my signature on improving care for Kenya's mothers and newborns

Angela Muriuki finds that combating the high death rates in mothers and newborns in parts of Kenya involves knowledge of the culture of the people involved and the practical problems they face accessing healthcare.

Less is more with advanced technologies in manufacturing

Using biology to increase quality and reduce carbon footprint

Five years. 40,000 health workers. 11 million people.

What happened when GSK committed to reinvest 20% of its profits from the least developed countries back into those nations’ healthcare systems?

Targeting the immune system through open innovation

A functioning immune system is crucial to our health - but what is its role beyond such things as keeping colds at bay and fighting infections?

To challenge. To change.

At GSK we’re taking on some of the world’s biggest healthcare challenges. We're on a mission to help people do more, feel better, live longer.

Health workers fighting it on the frontline

Almost everyone in Tanzania is at risk of malaria. The mosquito-borne disease is responsible for more than 10% of deaths among children under five in this East African country.

No 'silver bullet' to tackle this disease

On the frontline of Ebola prevention

Ebola: our fast track response

GSK responded to the crisis by contributing humanitarian support and accelerating the development of an investigational Ebola vaccine.

Keeping ahead of the game

To be the best at what we do, we rely on innovative science to create products capable of transforming the lives of patients.

Fluorescent bacteria - nowhere to hide

How can a new approach known as “bacteria-instructed synthesis” help to tackle bacterial infection?

Making our vaccines more accessible

We are determined to use our resources, knowledge and expertise to help improve access to immunisation.

Vaccines - coming in from the cold

Motivating a global coalition

Cell and gene therapy: a new era of medicine

If we can pinpoint a faulty gene and correct it, could we potentially find a way to cure genetic diseases?

Fighting Ebola highlights the need for more health workers

The Ebola crisis is by far the worst outbreak of the disease the world has ever seen.

The race to richer data in clinical trials

Finding new ways to use biosensors and mobile health platforms to improve patient care.

Why our transaction with Novartis is different

What makes GSK’'s transaction with Novartis different?

Ebola vaccine R&D

Forming public partnerships

Our humanitarian response to the Ebola outbreak

GSK's ongoing efforts to strengthen healthcare infrastructure in the most affected countries.

A healthier future for Africa

Our VP of east Africa and government affairs, Allan Pamba, explains his desire to improve the health of people in Africa.

The critical workers boosting children’s health

As a community health worker in Liberia – communities rely on people like Christopher for essential healthcare.

Flonase: the journey from prescription to OTC

Switching a product from a prescription medicine to over the counter (OTC) is nothing to sniff at.

Africa’s fight against malaria: how mothers are helping on the ground

Increasing access in India

Helping women to give birth safely

Helping midwives like Mary develop their skills and ensure more women give birth safely in Africa.

Science of a different stripe

How do the stripes in toothpaste get into the tubes and how is it that they come out of it so uniformly?

Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?

Can mosquitoes prevent malaria?

Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.

Data transparency

Neuroscience: on the brain

The 'baby bubble'

The first 48 hours of life can be critical for a newborn baby. Infections like pneumonia, contracted during a baby’s first two days, can prove fatal.

Eggs in manufacturing

Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need.

'Rightsizing' our tablet packaging to reduce carbon emissions

How can you fit six tablets into the same space as four – and why would you want to?

Green chemistry

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.

Life after polio: Fatiha's story